You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Investigational Drug Information for Nelotanserin


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Nelotanserin?

Nelotanserin is an investigational drug.

There have been 3 clinical trials for Nelotanserin. The most recent clinical trial was a Phase 2 trial, which was initiated on October 20th 2016.

The most common disease conditions in clinical trials are Lewy Body Disease, Dementia, and Hallucinations. The leading clinical trial sponsors are Axovant Sciences Ltd. and [disabled in preview].

Recent Clinical Trials for Nelotanserin
TitleSponsorPhase
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderAxovant Sciences Ltd.Phase 2
Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)Axovant Sciences Ltd.Phase 2
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body DementiaAxovant Sciences Ltd.Phase 2

See all Nelotanserin clinical trials

Clinical Trial Summary for Nelotanserin

Top disease conditions for Nelotanserin
Top clinical trial sponsors for Nelotanserin

See all Nelotanserin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.